<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02873949</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A00097-44</org_study_id>
    <nct_id>NCT02873949</nct_id>
  </id_info>
  <brief_title>Analysis of Soluble TREM (Triggering Receptor Expressed on Myeloid Cells)-1 and -2 in Crevicular Fluid and Associated Bacterial Flora in Patients Affected by Periodontitis</brief_title>
  <acronym>TREM</acronym>
  <official_title>Analysis of Soluble TREM (Triggering Receptor Expressed on Myeloid Cells)-1 and -2 in Crevicular Fluid and Associated Bacterial Flora in Patients Affected by Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Etiopathology of periodontitis is complex and various risk factors are known :&#xD;
&#xD;
        -  Bacterial factors: major risk factor. Although the presence of periodontopathogen&#xD;
           bacteria is necessary for the onset of periodontitis, these microorganisms are not&#xD;
           sufficient for progression of all periodontal disease.&#xD;
&#xD;
        -  Immune factor: host immune response modulates the disease evolution to destruction or&#xD;
           recovery. The most studied cytokine in periodontology is IL-1 that induces various&#xD;
           immune reactions and bone resorption directly or indirectly through the stimulation of&#xD;
           prostaglandin E2 (PGE2) release. PGE2 activates the matrix metalloproteinases that are&#xD;
           responsible of the degradation of bone extracellular matrix.&#xD;
&#xD;
      Cytokine production, especially TNFα, IL-1β, IL-6 and IL-8, by some immune cells is modulated&#xD;
      by new identified molecules such as Triggering Receptor Expressed on Myeloid cells (TREM)&#xD;
      whose role in periodontitis is unknown.&#xD;
&#xD;
      The purpose of this study is to compare concentrations of soluble TREM-1 and TREM-2 markers&#xD;
      in infected sites and in healthy sites in patients affected by periodontitis.&#xD;
&#xD;
      Other purposes are&#xD;
&#xD;
        1. Comparison of soluble TREM-1 and TREM-2 concentrations in healthy sites in patients&#xD;
           affected by periodontitis and in healthy patients&#xD;
&#xD;
        2. Comparison of soluble TREM-1 and TREM-2 concentrations before and after etiologic&#xD;
           periodontitis treatment&#xD;
&#xD;
        3. Estimation of the correlation between soluble TREM-1 and TREM-2 concentrations and&#xD;
           clinical signs of periodontitis&#xD;
&#xD;
        4. Description of soluble TREM-1/TREM-2 ratio before and after etiologic treatment&#xD;
&#xD;
        5. Description of presence of some bacteria in sites analyzed for soluble TREM-1 and TREM-2&#xD;
&#xD;
        6. Search for the most observed bacteria in presence of high concentrations of soluble&#xD;
           TREM-1 and TREM-2 before and after etiologic treatment&#xD;
&#xD;
        7. Evaluation of the impact of psychological stress measured through salivary cortisol&#xD;
           level in saliva on TREM-1 and -2 expression&#xD;
&#xD;
        8. Evaluation of the impact of psychological stress through stress and anxiety&#xD;
           auto-questionnaires (Spielberger and Cohen) on soluble TREM-1 and TREM-2 concentrations&#xD;
           in crevicular fluid of healthy and pathologic teeth.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average concentration (quantified with ELISA assay) of soluble TREM-1 and TREM-2 in crevicular fluid from 2 distant sites affected by periodontitis and 1 healthy site of each periodontitis patients at first consultation</measure>
    <time_frame>day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average concentration (quantified with ELISA assay) of soluble TREM-1 and TREM-2 in crevicular fluid from healthy sites of periodontitis patients and non-periodontitis patients at first consultation</measure>
    <time_frame>day 0</time_frame>
    <description>Crevicular fluid from 3 sites (2 distant affected by periodontitis and 1 healthy) of periodontitis patients and from 1 healthy site of non-periodontitis patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average concentration (quantified with ELISA assay) of soluble TREM-1 and TREM-2 in crevicular fluid of periodontitis patients before and after etiologic treatment of periodontitis</measure>
    <time_frame>day 0 and after 13 to 15 weeks (after etiologic treatment of periodontitis patients)</time_frame>
    <description>Crevicular fluid from 3 sites (2 distant affected by periodontitis and 1 healthy) of periodontitis patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification of periodontal bacterial flora</measure>
    <time_frame>day 0 and after 13 to 15 weeks (after etiologic treatment of periodontitis patients)</time_frame>
    <description>The kit microIDent®plus11 (Hain, Lifesciences) allows the identification by PCR of the most pathogen periodontal bacteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological stress score with Cohen Perceived Stress Scale</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological stress score with Spielberger State-Trait Anxiety Inventory</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantification of salivary cortisol by ELISA to measure psychological stress</measure>
    <time_frame>day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>1. Periodontitis patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 patients consulting at Odontology department for periodontal treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2. Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>10 patients not affected by periodontitis consulting at Odontology department for checkup of teeth state and/or scaling</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Crevicular samples (1-10µl)</intervention_name>
    <description>In periodontitis patients: from 2 sites affected by periodontitis and 1 healthy site, 2 samples/site, before and after treatment&#xD;
In non-periodontitis individuals: 2 samples from 1 site</description>
    <arm_group_label>1. Periodontitis patients</arm_group_label>
    <arm_group_label>2. Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Saliva samples (1ml)</intervention_name>
    <arm_group_label>1. Periodontitis patients</arm_group_label>
    <arm_group_label>2. Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Etiologic treatment</intervention_name>
    <description>education on oral hygiene, scaling and root planing</description>
    <arm_group_label>1. Periodontitis patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychometric tests</intervention_name>
    <description>Spielberger State-Trait Anxiety Inventory and Cohen Perceived Stress Scale</description>
    <arm_group_label>1. Periodontitis patients</arm_group_label>
    <arm_group_label>2. Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All:&#xD;
&#xD;
          -  Affiliation to social security plan&#xD;
&#xD;
          -  Absence of refusal of patient&#xD;
&#xD;
        Group 1. Periodontal patients:&#xD;
&#xD;
          -  Affected by moderate to severe chronic periodontitis&#xD;
&#xD;
          -  At least 2 distinct infected sites with periodontal pocket depth ≥ 5mm&#xD;
&#xD;
          -  Having not received any root planing during last 6 months before visit&#xD;
&#xD;
        Group 2. Control:&#xD;
&#xD;
          -  No periodontitis&#xD;
&#xD;
          -  Consulting for dental checkup and eventually scaling&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        All:&#xD;
&#xD;
          -  Pregnant women (change in bacterial flora) and breast-feeding&#xD;
&#xD;
          -  Administration of systemic antibiotherapy or any treatment influencing periodontal&#xD;
             environment (anti-inflammatory, anti-epileptic, immune-suppressor, calcium inhibitor)&#xD;
             during 6 months before sample collection&#xD;
&#xD;
          -  Patients having a pathology needing a prophylactic antibiotherapy (possibly&#xD;
             influencing the treatment)&#xD;
&#xD;
          -  Teeth with periapical inflammatory lesions of endodontic origin&#xD;
&#xD;
          -  Person under guardianship&#xD;
&#xD;
        Group 1. Periodontal patients:&#xD;
&#xD;
        - Root planing during last 6 months before visit&#xD;
&#xD;
        Group 2. Control:&#xD;
&#xD;
        - Periodontitis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine BISSON</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service Odontologie - Site Heydenreich - CHRU Nancy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sébastien GIBOT</last_name>
    <role>Study Chair</role>
    <affiliation>Service Réanimation Médicale - Hôpital Central - CHRU Nancy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service Odontologie - Site Heydenreich - CHRU Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>August 17, 2016</study_first_submitted>
  <study_first_submitted_qc>August 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2016</study_first_posted>
  <last_update_submitted>January 30, 2019</last_update_submitted>
  <last_update_submitted_qc>January 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>immunology factors</keyword>
  <keyword>TREM</keyword>
  <keyword>stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

